Your browser doesn't support javascript.
loading
Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom.
Claxton, Lindsay; Hodgson, Robert; Taylor, Matthew; Malcolm, Bill; Pulikottil Jacob, Ruth.
Affiliation
  • Claxton L; York Health Economics Consortium, University of York, York, UK. lindsay.claxton@york.ac.uk.
  • Hodgson R; York Health Economics Consortium, University of York, York, UK.
  • Taylor M; York Health Economics Consortium, University of York, York, UK.
  • Malcolm B; Novartis Pharmaceuticals UK Limited, Frimley Business Park, Surrey, UK.
  • Pulikottil Jacob R; Novartis Pharmaceuticals UK Limited, Frimley Business Park, Surrey, UK.
Pharmacoeconomics ; 35(2): 237-248, 2017 02.
Article in En | MEDLINE | ID: mdl-27787744
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Models, Economic / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Europa Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Models, Economic / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Europa Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: New Zealand